Skip to content
Goserelin
Zoladex (goserelin) is a protein pharmaceutical. Goserelin was first approved as Zoladex on 1989-12-29. The pharmaceutical is active against gonadotropin-releasing hormone receptor.
Download report
Favorite
Top 200 Pharmaceuticals by Retail Sales
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Zoladex
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Goserelin acetate
Tradename
Company
Number
Date
Products
ZOLADEXTerSera TherapeuticsN-019726 RX1989-12-29
1 products, RLD, RS
ZOLADEXTerSera TherapeuticsN-020578 RX1996-01-11
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
zoladexNew Drug Application2021-06-30
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
L: Antineoplastic and immunomodulating agents
L02: Endocrine therapy antineoplastic and immunomodulating agents
L02A: Hormones and related agents
L02AE: Gonadotropin releasing hormone analogues, endocrine therapy drugs
L02AE03: Goserelin
HCPCS
Code
Description
J9202
Goserelin acetate implant, per 3.6 mg
S9560
Home injectable therapy; hormonal therapy (e.g.; leuprolide, goserelin), including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem
Clinical
Clinical Trials
112 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Prostatic neoplasmsD011471C61221202852
InfertilityD007246EFO_000054531115
Kallmann syndromeD017436Orphanet_478E23.01135
Female infertilityD007247EFO_0008560N9711113
Fertilization in vitroD005307112
EndometriosisD004715EFO_0001065N8022
Ovarian reserveD065851EFO_000477011
Polycystic ovary syndromeD011085EFO_0000660E28.211
AmenorrheaD000568N91.211
Cardiovascular diseasesD002318EFO_0000319I9811
Show 2 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C5027311
HypogonadismD007006E23.0121610
Triple negative breast neoplasmsD06472633
Precocious pubertyD011629E22.8112
OsteoporosisD010024EFO_0003882M81.0112
Embryo transferD00462411
Ductal carcinoma breastD018270111
Inflammatory breast neoplasmsD058922111
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AdenocarcinomaD00023033
Male breast neoplasmsD01856711
Olfaction disordersD000857R43.011
Down syndromeD004314EFO_0001064Q9011
Alzheimer diseaseD000544EFO_0000249F0311
Cognitive dysfunctionD060825G31.8411
HyperprolactinemiaD006966E22.111
Erectile dysfunctionD007172EFO_0004234F52.2111
Lower urinary tract symptomsD059411EFO_000800811
Ovarian neoplasmsD010051EFO_0003893C5611
Show 1 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Cocaine-related disordersD019970F1411
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ObesityD009765EFO_0001073E66.922
Ovulation inductionD01006211
Spinal cord injuriesD013119EFO_100191911
Gonadal disordersD00605811
PorphyriasD011164EFO_0000665E80.2011
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameGOSERELIN
INNgoserelin
Description
Goserelin is an organic molecular entity.
Classification
Protein
Drug classprehormones or hormone-release stimulating peptides
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CC(C)C[C@H](NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NNC(N)=O
Identifiers
PDB
CAS-ID65807-02-5
RxCUI50610
ChEMBL IDCHEMBL1201247
ChEBI ID
PubChem CID5311128
DrugBankDB00014
UNII ID0F65R8P09N (ChemIDplus, GSRS)
Target
Agency Approved
GNRHR
GNRHR
Organism
Homo sapiens
Gene name
GNRHR
Gene synonyms
GRHR
NCBI Gene ID
Protein name
gonadotropin-releasing hormone receptor
Protein synonyms
gnRH receptor, gnRH-R, gonadotropin-releasing hormone (type 1) receptor 1, leutinizing hormone releasing horomone receptor, leutinizing-releasing hormone receptor, luliberin receptor, type I GnRH receptor
Uniprot ID
Mouse ortholog
Gnrhr (14715)
gonadotropin-releasing hormone receptor (Q61611)
Alternate
No data
Variants
Clinical Variant
No data
Financial
Zoladex - AstraZeneca
$
£
Mock data
Subscribe for the real data
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 4,349 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
225 adverse events reported
View more details